Cipla gets VAI classification from USFDA for Patalganga facility 0 25.06.2024 09:04 Business Standard Cipla said that US Food and Drug Administration (USFDA) classified the inspection conducted at Patalganga, Maharashtra facility as Voluntary Action Indicated (VAI). Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
